SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63321 355 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63293My friends at Wells Fargo were bigger supporters. it's cost me But they fouEMU2-November 12
63292Anavex (AVXL) had a preauthorization oral explanation meeting with the FDA yesteOlecranon1November 12
63291re: GLUE up 14% after a poster presentation? Poster presentation Saturday All erickerickson1November 10
63290Finally out of Auph with a nice profit. Had to average down a number of times bgalt-November 9
63289AUPH is gaining on SRPT, who would have thought.idahoranch12November 7
63288Gilead fails late-stage trial for Trodelvy in first-line breast cancerDavidoff-November 7
63287Expert witness hahaha. These Federal F*cks just copy and pasted everything Heilbghettogoulash1November 7
63286Just saw this. The U.S. Department of Justice dismissed with prejudice all chargghettogoulash2November 7
63285I continue to be impressed by the number of ways there are to lose holding a bioallatwwk6November 5
63284Two things I don't like about Sarepta's spin on trial data: (1) The Statghettogoulash1November 5
63283Indeed, this will be a tough sell to Prasad & Co. Then again, it's gonnaghettogoulash2November 5
63282Olecranon, I share your general concern about Sarepta. I think for EXONDYS 51 ibodish3November 4
63281I’ve been maybe Sarepta’s biggest permabull. This really puts a hitch in my giddOlecranon1November 4
63280> which could impact the transition from accelerated to traditional approval li35113November 4
63279> How can a public figure make such statements that they know will move the mli35111November 4
63278Srpt. The ESSENCE trial did not reach statistical significance on its primary enerippetoe1November 4
63277Case 1:25-cv-03593 Document 1 Filed 11/02/25 Page 1 of 32 IN THE UNITED STATES dorightbythem2November 3
63276Me too, just find it interestingerippetoe-October 28
63275I will be avoiding this.Olecranon-October 28
63274SRPU - tradr 2x long SRPT appears to have just started trading Thur? Interestinerippetoe-October 25
63273I don’t own any either, but I sure do like seeing that the combined knowledge anidahoranch119October 23
63272Thanks for sharing. I currently don’t own any GILD so haven’t followed as much aerippetoe-October 20
63271Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotjargonweary13October 20
63270SRPT: I was unaware of this. Sarepta is co-developing another promising, late stghettogoulash4October 11
63269Thanks GG. You were spot on about the PR, released this morning, about World Musbodish1October 3
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News